Global

‡ In these countries please contact our distributor

RENASYS EVIDENCE

This information is intended for HCPs in the US.
Please consult your local Smith + Nephew representative for further details on products available in your market. 

 

Backed by clinical evidence


RENASYS TOUCH and RENASYS GO tNPWT systems are supported by a growing body of clinical evidence.


Key evidence highlights

Read: Single paper review: A retrospective comparison of the performance of two negative pressure wound therapy systems in the management of wounds of mixed aetiology

Read: A randomised controlled trial to compare the clinical efficacy and acceptability of adjustable intermittent and continuous Negative Pressure Wound Therapy (NPWT) in a new portable NPWT system 

Read: An interim analysis of device functionality and usability of RENASYS TOUCH - a new portable Negative Pressure Wound Therapy (NPWT) system

Additional clinical evidence

Read: The ability of commercial NPWT Systems to manage fluid in an experimental open abdomen study

Read: Retrospective chronic and postsurgical wound case series: Understanding RENASYS TOUCH


Need help?

For further information and guidance, please contact us

Important Safety Information
The information herein is intended for healthcare professionals. RENASYS is contraindicated in the presence of untreated osteomyelitis, exposed arteries/veins/organs/nerves, necrotic tissue with eschar present, malignancy in the wound, non-enteric and unexplored fistulas, and exposed anastomotic sites. Excessive bleeding is a serious risk associated with the application of suction to wounds, which may result in death or serious injury. For full product and safety information, please see the Instructions for Use.

Important Safety Information

 

The information herein is intended for healthcare professionals. RENASYS is contraindicated in the presence of untreated osteomyelitis, exposed arteries/veins/organs/nerves, necrotic tissue with eschar present, malignancy in the wound, non-enteric and unexplored fistulas, and exposed anastomotic sites. Excessive bleeding is a serious risk associated with the application of suction to wounds, which may result in death or serious injury. For full product and safety information, please see the Instructions for Use.

RENASYS◊  GO
Post-Acute NPWT Solution in the United States

Order your RENASYS GO pump in the US through Rotech Healthcare, Inc.

Download now

Intended for HCPs in the US only